Annual revenue fell from KRW 137.2 billion in 2022 to KRW 136 billion in 2023, a 0.9% decline, then rose to KRW 179.9 billion in 2024, up 32.3%. Among 2022 to 2025, 2024 was the year with the largest revenue, and 2025 revenue of KRW 172.3 billion declined 4.2% from the prior year.
Operating profit went from KRW 7.78 billion in 2022 to KRW 983 million in 2023, down 87.4%, then to KRW 6.56 billion in 2024, up 567.7%, before swinging to an operating loss of KRW 4.96 billion in 2025. The operating margin moved from 5.7% in 2022 to 0.7% in 2023 and 3.6% in 2024, and was -2.9% in 2025.
For 2024, the company attributed the improvement to strong performance across its EPC business, healthcare business and bio business at subsidiary Cellontech, according to a February 2025 press report.
For the 2025 swing to a loss, the company cited higher subcontracting costs that raised the cost of sales ratio, along with higher commission and advertising expenses, in its February 2026 disclosure.
Net income attributable to controlling shareholders was KRW 5.46 billion in 2022, a net loss of KRW 2.36 billion in 2023, a profit of KRW 3.72 billion in 2024, and a net loss of KRW 4.75 billion in 2025.
Net income including non-controlling interests was KRW 7.14 billion in 2022, larger than the controlling-shareholder figure that year. The debt-to-equity ratio fell from 158.2% in 2022 and 143.9% in 2024 but rose to 188.8% in 2025, when total liabilities were KRW 89.1 billion against total equity of KRW 47.2 billion.
Operating cash flow was KRW 7.65 billion in 2022, negative KRW 2.99 billion in 2023, KRW 6.38 billion in 2024 and KRW 3.82 billion in 2025.
On a quarterly basis, revenue was KRW 48.1 billion in the third quarter of 2025, KRW 44.7 billion in the fourth quarter, KRW 19.3 billion in the first quarter of 2026, KRW 13.8 billion in the second quarter and KRW 21 billion in the third quarter.
Third-quarter 2026 revenue rose 52.1% from the previous quarter but fell 56.2% from a year earlier.
Operating results were an operating loss of KRW 5.23 billion in the third quarter of 2025, an operating profit of KRW 948 million in the fourth quarter, and operating losses of KRW 1.84 billion, KRW 3.98 billion and KRW 3.07 billion in the first three quarters of 2026.
Net income attributable to controlling shareholders was a loss of KRW 4.69 billion in the third quarter of 2025, a profit of KRW 1.28 billion in the fourth quarter, and losses of KRW 3.1 billion, KRW 4.97 billion and KRW 3.77 billion in the first three quarters of 2026.
The net loss attributable to controlling shareholders over the last four quarters totals KRW 10.6 billion. Because EPC revenue is recognized by construction progress, according to a October 2026 Seoul Economic TV report, the pace at which orders convert into revenue drives quarterly volatility.